By: ICN Bureau
Last updated : October 23, 2026 6:48 pm
The discussion will feature prominent experts representing major innovators, manufacturers, and academic bodies: Dr. Marco Busch, Global Head – Ag Research and Development, PI Industries; Dr. Kamlesh Pai Fondekar, Head - R&D, Godrej Agrovet; Dr. Amit Rastogi, Executive Vice President & Chief Technology Officer, Coromandel International; Dr. Surender Kumar Dhingra, Sr. Vice President and Head - R&D, Jubilant Ingrevia, Dr. Shrikant J. Wagh, Provost, UPL University of Sustainable Technology and Abijar Bhori, Associate Vice President and Head of Purification Process Development, Enzene Biosciences.
Indian Chemical News and Indian Pharma Post are jointly organizing the highly anticipated ChemPharma R&D Summit 2026, scheduled to take place on October 27–28, 2026, at the Courtyard by Marriott Mumbai International Airport, Mumbai. Anchored by the core theme of "Innovation, Digital Transformation, and Sustainability," this premier event serves as a critical nexus for industry advancements.
The agenda of the Summit is available Here. One can register on the below given Link:
https://www.indianchemicalnews.com/chempharma_r_and_d_summit_2026//register.php
A specialized industry session titled "Strategic R&D Partnerships: Rise of Pharma and Agrochemicals CDMO" is set to take center stage at the ChemPharma R&D Summit 2026 on October 27, 2026.
The session will bring together an elite panel of scientists, corporate executives, and technology leaders to unpack how Contract Development and Manufacturing Organizations (CDMOs) are transforming global supply chains and value creation.
Moderated by Pravin Prashant, Executive Editor of Indian Chemical News, the discussion will feature prominent experts representing major innovators, manufacturers, and academic bodies: Dr. Marco Busch, Global Head – Ag Research and Development, PI Industries; Dr. Kamlesh Pai Fondekar, Head - R&D, Godrej Agrovet; Dr. Amit Rastogi, Executive Vice President & Chief Technology Officer, Coromandel International; Dr. Surender Kumar Dhingra, Sr. Vice President and Head - R&D, Jubilant Ingrevia, Dr. Shrikant J. Wagh, Provost, UPL University of Sustainable Technology and Abijar Bhori, Associate Vice President and Head of Purification Process Development, Enzene Biosciences.
As global market realignments push companies beyond simple cost-arbitrage towards innovation-led value, the CDMO sector has transitioned from a transactional vendor model to a deeply integrated strategic partnership framework.
The speakers will address seven core areas vital to the sector’s evolution: Co-Development and Risk-Sharing Models, Integration of Advanced Technologies, Specialized Expertise in Complex Modalities, Regulatory Harmonization and Quality Compliance, Supply Chain Resilience and Nearshoring, Environmental, Social, and Governance (ESG) Goals and Talent Retention and Workforce Upskilling.
The ChemPharma R&D Summit 2026 is structured as an action-oriented forum designed to bridge industry execution with forward-looking policies, charting India’s course toward becoming a dominant global hub for science-led industrial innovation.